Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia / reperfusion injury.
High-intensity interval training
Myocardial infarction
Necroptosis
Oxidative stress
Post-ischemic adverse remodelling
Journal
Journal of cell communication and signaling
ISSN: 1873-9601
Titre abrégé: J Cell Commun Signal
Pays: Netherlands
ID NLM: 101308338
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
16
03
2018
accepted:
11
07
2018
pubmed:
4
8
2018
medline:
4
8
2018
entrez:
4
8
2018
Statut:
ppublish
Résumé
Regulated necrosis (necroptosis) plays a pivotal role in the extent of cardiomyocyte loss and the development of post-ischemic adverse remodelling and cardiac dysfunction following myocardial I/R injury. Although HIIT has been reported to give rise to cardioprotection against MI, but the detailed knowledge of its molecular targets for treatment of MI is still not available. The LAD of Male Wistar rats was occluded to induce MI for 30 min and reperfusion for eight weeks. We investigated the effect of long-term HIIT for eight weeks on lipid peroxidation, SOD activity and GSH content using ELISA assay. Cardiac function, fibrosis, and infarct size were assessed by echocardiography, Masson's trichrome and Evans Blue/TTC dual staining respectively. The expressions of gene markers of myocardial hypertrophy, fibrosis and key mediators of necroptosis were measured using RT-PCR and western blotting assay respectively. The results indicated that HIIT reduced lipid peroxidation, infarct size and improved endogenous antioxidant system and heart function. Significant decreases in mRNA levels of procollagen α1(I), α1(III), and fibronectin1were observed following HIIT. Moreover, that HIIT significantly decreased the expression of key mediators of necroptosis induced by MI (P < 0.05). There were no significant differences in β-MHC mRNA level in different groups. The findings of study suggest that HIIT might exert cardioprotective effects against post-ischemic adverse remodeling through targeting necroptosis process. Likewise, cardioprotective effects of HIIT in coping with myocardial I/R injury may be associated with RIP1-RIP3-MLKL axis. These findings establish a critical foundation for higher efficiency of exercise-based cardiac rehabilitation post-MI and future research.
Identifiants
pubmed: 30073629
doi: 10.1007/s12079-018-0481-3
pii: 10.1007/s12079-018-0481-3
pmc: PMC6498245
doi:
Types de publication
Journal Article
Langues
eng
Pagination
255-267Références
Circulation. 2014 Dec 9;130(24):2162-72
pubmed: 25278099
Life Sci. 2017 Nov 15;189:8-17
pubmed: 28893641
Biochimie. 2017 Nov;142:63-79
pubmed: 28807562
J Mater Chem B. 2017 Dec 28;5(48):9452-9476
pubmed: 32264560
Cell. 2009 Jul 23;138(2):229-32
pubmed: 19632174
Cell Biochem Biophys. 2007;47(1):11-20
pubmed: 17406056
Apoptosis. 2014 Apr;19(4):567-80
pubmed: 24248985
Cell Physiol Biochem. 2015;37(1):162-75
pubmed: 26303678
Trends Cell Biol. 2016 Oct;26(10):721-732
pubmed: 27368376
Science. 2009 Jul 17;325(5938):332-6
pubmed: 19498109
Sports Med. 2012 Jul 1;42(7):587-605
pubmed: 22694349
Br J Sports Med. 2017 Mar;51(6):494-503
pubmed: 27797726
Am J Physiol Regul Integr Comp Physiol. 2017 Feb 1;312(2):R197-R210
pubmed: 27784688
Nat Nanotechnol. 2017 Sep 6;12(9):845-855
pubmed: 28875984
Cancer Gene Ther. 2016 Oct;23(10):365-369
pubmed: 27740614
Cardiovasc Res. 2014 Jul 15;103(2):206-16
pubmed: 24920296
World J Cardiol. 2015 Feb 26;7(2):52-64
pubmed: 25717353
Cardiovasc Res. 2013 Jul 1;99(1):55-64
pubmed: 23554460
Basic Res Cardiol. 2012 Jul;107(4):270
pubmed: 22553001
Anal Biochem. 1971 Nov;44(1):276-87
pubmed: 4943714
Ageing Res Rev. 2016 Nov;31:55-66
pubmed: 27453478
Iran J Basic Med Sci. 2016 Mar;19(3):258-64
pubmed: 27114795
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2178-2183
pubmed: 29269294
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1814-20
pubmed: 11247796
Clin Chim Acta. 1994 Nov;231(1):47-60
pubmed: 7704948
Pharm Biol. 2016 Oct;54(10):2211-9
pubmed: 26960058
Anal Biochem. 1972 Apr;46(2):639-53
pubmed: 4623507
Am J Physiol Heart Circ Physiol. 2015 Jul 15;309(2):H345-59
pubmed: 26001415
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):315-24
pubmed: 23224706
Neurosci Biobehav Rev. 2017 Feb;73:39-47
pubmed: 27914941
Biochem Biophys Res Commun. 2013 Jun 28;436(2):212-6
pubmed: 23727581
EXCLI J. 2015 Feb 20;14:237-46
pubmed: 26417361
Cardiovasc Toxicol. 2018 Aug;18(4):346-355
pubmed: 29299822
Int Heart J. 2017 Aug 3;58(4):615-623
pubmed: 28701679
Kidney Int. 2012 Apr;81(8):751-61
pubmed: 22237751
Nat Med. 2016 Feb;22(2):175-82
pubmed: 26726877
Int J Sports Med. 2017 Jan;38(1):27-34
pubmed: 27737487
J Anesth. 2014 Apr;28(2):235-41
pubmed: 24113863
Fundam Clin Pharmacol. 2013 Dec;27(6):593-602
pubmed: 22943605
Cell Death Differ. 2016 Sep 1;23(9):1565-76
pubmed: 27177019
Clin Exp Pharmacol Physiol. 2007 Apr;34(4):255-62
pubmed: 17324134
Pharmacol Rep. 2015 Dec;67(6):1090-7
pubmed: 26481526
Cardiovasc Res. 2009 Feb 15;81(3):465-73
pubmed: 18779231
Fundam Clin Pharmacol. 2010 Apr;24(2):189-98
pubmed: 19686533
Clin Sci (Lond). 2015 Dec;129(12):1097-105
pubmed: 26265792
Methods Enzymol. 1990;186:407-21
pubmed: 2233308
Immunity. 2013 Feb 21;38(2):209-23
pubmed: 23438821
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275
pubmed: 27751237
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
pubmed: 20823910
Fundam Clin Pharmacol. 2003 Oct;17(5):595-8
pubmed: 14703720
Nat Cell Biol. 2014 Jan;16(1):55-65
pubmed: 24316671
Curr Vasc Pharmacol. 2015;13(1):26-36
pubmed: 23628007
J Cell Sci. 2012 Jun 15;125(Pt 12):2995-3003
pubmed: 22393233
Curr Opin Cell Biol. 2010 Apr;22(2):263-8
pubmed: 20045303